Last Updated on October 2, 2024 by The Health Master
“The Drugs Controller General of India (DCGI) gives permission for a 14-valent pediatric pneumococcal conjugate vaccine (Investigational Pneumococcal Polysaccharide Conjugate Vaccine PCV14) against S. pneumoniae infection,” announced Biological E. Limited (BE), a Hyderabad-based pharmaceutical and vaccine company.
PCV14 may be administered to infants 6, 10, and 14 weeks of age in 3 doses.
Streptococcus pneumoniae infection remains one of the leading causes of death among children under the age of five in India and in developing countries.
BE’s PCV14 Vaccine will help prevent invasive pneumococcal infection and save millions of lives worldwide.
BE’s PCV14 contains 14 serotypes (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F).
BE’s PCV14 contains the largest number of serotypes in India and offers expanded protection against two new serotypes 22F and 33F.
These new serotypes have been reported recently to be causing infections. In a phase 3 infants trial BE’s PCV14 was non-inferior to all the common serotypes present in the comparator’s vaccine.
The primary immunogenicity objective of demonstrating non-inferiority with anti-PnCPS IgG antibody concentrations against each of the 12 common serotypes of BE-PCV14 vaccine in terms of subjects seroconverted and the ratio of geometric mean concentrations against corresponding serotypes in active comparator was met.
Non-inferiority was demonstrated with anti-PnCPS IgG antibody concentrations against unique serotypes 22F and 33F specific to BE-PCV14.
The immune response to serotype 6A not present in BE’s PCV14 was also achieved through cross-protection from vaccine serotype 6B present in BE-PCV14.
The safety comparison demonstrates that the BE-PCV14 vaccine was well-tolerated and considered safe.
BE’s PCV14 is comparable in terms of serotype coverage for infants to the two globally approved pneumococcal conjugate vaccines Prevenar13 and Merck’s Vaxneuvance.
CDSCO Panel gives nod for FDC Tamsulosin + Solifenacin
CDSCO panel gives nod for Esomeprazole Dual Release Gastro resistant Tablets
CDSCO gives approval for this Anti-diabetic drug
CDSCO gives nod to Dapagliflozin Tablets
CDSCO approves 4 more Medical Device Testing Labs (MDTL)
DCGI gives nod to Intranasal C-19 booster dose
FDA Goa directs Medical Device Cos to get license for Class A & B
Bulk transfer of Blood and Blood Components: Procedure and Conditions
USFDA issues warning letter to Sun Pharma for Halol facility
IPC flags drug safety alert against Minoxidil
USFDA issues Form 483 with 8 observations to Jubilant
NPPA releases 5th list of draft ceiling prices for 69 formulations
DCOIWA to conduct workshops on Drugs & Medical Devices
International drug racket busted in Hyderabad, two held
Drug alert: 83 out of 1487 samples declared as NSQ in November 20222
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
